Argenica Therapeutics Ltd Sustainability Reports

Argenica Therapeutics Ltd is a clinical-stage biotechnology company focused on developing novel neuroprotective therapeutics to reduce brain tissue death following a stroke or other central nervous system injuries.

Sector: Manufacturing

Country: Australia

Exchange: Australian Securities Exchange

FIGI: BBG010YS0TL2

7 reports from 2021 to 2026

• Argenica Therapeutics Ltd 2026 Appendix 4G Key to Disclosures
• Argenica Therapeutics Ltd 2025 Appendix 4G Key to Disclosures
• Argenica Therapeutics Ltd 2025 Appendix 4E Final Report
• Argenica Therapeutics Ltd 2023 Appendix 4E Final Report
• Argenica Therapeutics Ltd 2022 Appendix 4E Final Report